As the leading AI-based microbiome drug development company in China, Xbiome is dedicated to gut microbiome using AI techniques, and committed to the gut health of human being with medical treatments and precise and personalized management. Unlike the traditional paradigm of drug discovery, Xbiome's approach innovatively combines microbial technologies, artificial intelligence, bioinformatics analysis and gut microbiome technologies into a unique drug development platform, which substantially speeds up and improves the success rate of new drug development.